Open company graph database — free web & API
Login

DAIICHI SANKYO Singapore Pte. Ltd.

第一三共シンガポール株式会社Alias
Ticker
—
Listed market
—
Country
Singapore
Employees (non-consolidated)
—
Related companies
31
§01

Basic information

BASIC
Head office
未記載
Chief executive
未記載
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

0
§04

Related companies

31 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
DAIICHI SANKYO (CHINA) HOLDINGS CO., LTD.
Group
DAIICHI SANKYO Australia Pty Ltd
Group
Daiichi Sankyo Healthcare Co., Ltd.
Group
DAIICHI SANKYO HONG KONG LIMITED
Group
Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd.
Group
DAIICHI SANKYO TAIWAN LTD.
Group
DAIICHI SANKYO (SCHWEIZ) AG
Group
DAIICHI SANKYO AUSTRIA GmbH
Group
DAIICHI SANKYO BELGIUM N.V.-S.A.
Group
DAIICHI SANKYO BRASIL FARMACÊUTICA LTDA.
Group
Daiichi Sankyo Germany GmbH
Group
DAIICHI SANKYO ESPAÑA, S.A.U.
Group
DAIICHI SANKYO EUROPE GmbH
Group
DAIICHI SANKYO FRANCE SAS
Group
DAIICHI SANKYO Greece Single Member S.A.
Group
DAIICHI SANKYO Pharmaceutical, Trading Ltd. Co.
Group
DAIICHI SANKYO IRELAND LIMITED
Group
DAIICHI SANKYO ITALIA S.p.A.
Group
DAIICHI SANKYO Netherlands B.V.
Group
DAIICHI SANKYO NORDICS ApS
Group
DAIICHI SANKYO Pharma Canada Limited
Group
DAIICHI SANKYO PORTUGAL, UNIPESSOAL Lda.
Group
DAIICHI SANKYO UK LTD.
Group
DAIICHI SANKYO KOREA CO., LTD.
Group
American Regent, Inc.
Group
DAIICHI SANKYO (THAILAND) LTD.
Group
Daiichi Sankyo Biotech Co., Ltd.
Group
Daiichi Sankyo Business Associe Co., Ltd.
Group
Daiichi Sankyo Colombia, Sociedad por Acciones Simplificadas
Group
Daiichi Sankyo Mexico, Sociedad Anomina de Capital Variable
Group
DAIICHI SANKYO VIETNAM COMPANY LIMITED
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

58 EVENTS

Founded as Sankyo Shoten through a joint investment by businessmen Matasaku Shiobara, Shotaro Nishimura and Genjiro Fukui.Sources

Launched digestive enzyme Taka-Diastase® (in 1894, Dr. Jokichi Takamine discovered the enzyme from a fungus).Sources

Launched Adrenalin®, an adrenal cortex hormone agent.Sources

Established plant in Shinagawa, Japan.Sources

Dr. Umetaro Suzuki, a future Sankyo scientific adviser, made the world's first discovery of vitamin B1 (Orizanin®) in rice bran and established a foundation for the theory of vitamins.Sources

Changed company name from Sankyo Shoten to Sankyo Co., Ltd. and appointed Dr. Jokichi Takamine as first president.Sources

Founded as Arsemin Shokai by Dr. Shozaemon Keimatsu and five othersSources

Launched Arsemin®, an antisyphilitic agentSources

Launched Neo-Arsemin®, another antisyphilitic agentSources

Changed company name from Arsemin Shokai to Daiichi Pharmaceutical Co., Ltd. Appointed Seinosuke Shibata as first presidentSources

Began manufacturing Japan's first synthetic agricultural chemical, the fumigant insecticide KOKUZOL®.Sources

Launched Bosmin®, a vasoconstriction / hemostasis and asthma medicineSources

Established plant in Takatsuki, JapanSources

Listed on Tokyo Stock Exchange.Sources

Launched Therapol®, the first sulfa drug produced in JapanSources

Established plant in Funabori, JapanSources

Listed on Tokyo Stock ExchangeSources

Launched LULU® cold medicine.Sources

Manufactured Chloromycetin®, the first antibiotic produced in Japan.Sources

Launched Iscotin®, a medicine for tuberculosisSources

Launched Sankyo Ichoyaku (now Daiichi Sankyo Ichoyaku).Sources

Launched Vitamedin®, a vitamin B1, B6 and B12 compound.Sources

Completed construction of head office building in Nihonbashi, JapanSources

Launched Transamin®, an antiplasmin medicineSources

Established plant in Hiratsuka, Japan.Sources

Launched Patecs®, the first form-fitting pain relief patchSources

Beginning of the period 1970–2004, marking ongoing development.Sources

Launched Karoyan®, a hair restoration agentSources

Launched Krestin®, an anticancer drug.Sources

Launched Neuer®, a peptic ulcer agentSources

Launched Cefmetazon®, a cephamycin-type antibiotic.Sources

Established plant in Akita, JapanSources

Launched Captoril®, the world's first renin-angiotensin-type hypertensive drug.Sources

Signed out-licensing agreement for Tarivid®, a broad-spectrum antibacterial agent, with Johnson & Johnson of the United States and Hoechst of GermanySources

Launched Zantac®, a therapeutic agent for peptic ulcers.Sources

Established Sankyo USA Corporation in New York City and Sankyo Europe GmbH in Dusseldorf, Germany.Sources

Launched natural-type interferon-β formulation Feron®Sources

Launched Tarivid® in Japan and then-West GermanySources

Launched Loxonin®, an analgesic and anti-inflammatory agent.Sources

Established plant in Onahama, Japan.Sources

Launched Omnipark®, a contrast mediaSources

Launched Senlock Pellet® (now Daiichi Sankyo Core Block®), a gastrointestinal agentSources

Launched Regain®, a mini-bottled vitamin tonic.Sources

Globally launched Mevalotin®, a groundbreaking HMG-CoA reductase inhibitor (hyperlipidemic drug). Launched Banan®, an antibiotic agent.Sources

Invested in Luitpold-Werk GmbH Group.Sources

Established Korea Daiichi Pharmaceutical Co., Ltd.Sources

Awarded the Ohkochi Memorial Grand Production Prize for Mevalotin®.Sources

Launched Cravit®, a broad-spectrum oral antibacterial agentSources

Completed construction of head office building in Nihonbashi, Japan.Sources

Launched Acecol®, an antihypertensive agent.Sources

Launched Kuromaru Drink®, a digestive tonicSources

Established Sankyo Pharma Inc. in New Jersey, United States.Sources

Became the first pharmaceutical company in Japan to receive ISO 14001 environmental certification for its Onahama and Odawara plants. Established Sankyo Pharma Research Institute in California, United States.Sources

Established Daiichi Pharmaceutical (Beijing) Co., Ltd. in ChinaSources

Launched Fastic®, a drug for lowering blood sugar, and Olmesartan (Benicar® in the US and Olmetec® in Germany), an antihypertensive agent.Sources

Launched Calblock®, a long-acting calcium channel blocker.Sources

Launched Cystina C®, an over-the-counter vitamin C productSources

Launched Olmesartan in Japan.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑